INS and diabetes mellitus: In their metabolomic study, Koh and Backhed37 reported that imidazole propionate is present at higher concentrations in the plasma of patients with diabetes; the authors also hypothesized that imidazole propionate impairs insulin signaling by impairing the mechanistic target of rapamycin complex 1 (i.e., mTORC1).